K122199 is an FDA 510(k) clearance for the PREXION3D ECLIPSE. Classified as X-ray, Tomography, Computed, Dental (product code OAS), Class II - Special Controls.
Submitted by The Yoshida Dental Mfg. Co., Ltd. (Chiyoda-Ku, Tokyo, JP). The FDA issued a Cleared decision on April 18, 2013 after a review of 268 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.